Envista Holdings NVST
NYSE NVST
$27.20 +0.27 (+1.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Envista Holdings (NVST) Change in Accured Expenses (2018 - 2026)

Envista Holdings (NVST) posted quarterly Change in Accured Expenses of -$39.8 million for Q2 2026, down 5075.0% year-over-year from $800000.0 in Q2 2025, and down 289.52% quarter-over-quarter from $21.0 million in Q4 2025.

Envista Holdings (NVST) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Envista Holdings' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$39.8 million for Q2 2026.

  • In Q2 2026, Change in Accured Expenses fell 5075.0% year-over-year to -$39.8 million; the TTM figure through Apr 2026 stood at $75.4 million (down 42.44% YoY), while the FY2025 annual figure was $116.0 million, down 13.75% from the prior year.
  • Change in Accured Expenses for Q2 2026 stood at -$39.8 million, down from $21.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $52.4 million in Q2 2024, with the low at -$51.5 million in Q2 2022.
  • The 5-year median for Change in Accured Expenses is $4.3 million (2024), against an average of $3.9 million.
  • The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses soared 3790.91% in 2024, then sank 5075.0% in 2026.
  • Envista Holdings' Change in Accured Expenses stood at -$23.3 million in 2022, then jumped by 160.52% to $14.1 million in 2023, then soared by 148.23% to $35.0 million in 2024, then sank by 40.0% to $21.0 million in 2025, then slumped by 289.52% to -$39.8 million in 2026.
  • Business Quant data shows NVST's Change in Accured Expenses at -$39.8 million in Q2 2026, $21.0 million in Q4 2025, and $50.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 55.00 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 50.56 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 119.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 50.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 29.00 Mn
10 Envista Holdings 4.40 Bn 3.27 Bn 407.00 Mn 7.40 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 7.40 Mn
Jul 3, 2026 7.40 Mn
Apr 3, 2026 -39.80 Mn
Apr 3, 2026 -39.80 Mn
Dec 31, 2025 21.00 Mn
Dec 31, 2025 21.00 Mn
Sep 26, 2025 50.50 Mn
Sep 26, 2025 50.50 Mn
Jun 27, 2025 43.70 Mn
Jun 27, 2025 43.70 Mn
Mar 28, 2025 800,000.00
Mar 28, 2025 800,000.00
Dec 31, 2024 35.00 Mn
Dec 31, 2024 35.00 Mn
Sep 27, 2024 42.80 Mn
Sep 27, 2024 42.80 Mn
Jun 28, 2024 52.40 Mn
Jun 28, 2024 52.40 Mn
Mar 29, 2024 4.30 Mn
Mar 29, 2024 4.30 Mn